[HTML] scielo.br

[HTML][HTML] The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan, P Capelleti… - Revista brasileira de …, 2011 - SciELO Brasil
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …
被引用次数：5 相关文章

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan… - … de Hematologia e …, 2011 - augusta.elsevierpure.com
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …
[HTML] nih.gov

[HTML][HTML] The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan, P Capelleti… - Revista Brasileira de …, 2011 - ncbi.nlm.nih.gov
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan… - … de hematologia e …, 2011 - pubmed.ncbi.nlm.nih.gov
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan, P Capelleti, M Lima… - 2011 - lareferencia.info
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan… - Rev. bras. hematol …, 2011 - pesquisa.bvsalud.org
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan… - … de Hematologia e …, 2011 - ohiostate.elsevierpure.com
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …
[PDF] scienceopen.com

[PDF][PDF] The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan… - Rev Bras Hematol …, 2011 - scienceopen.com
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …
[HTML] scielo.br

[HTML][HTML] The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan, P Capelleti… - Revista Brasileira de …, 2011 - SciELO Brasil
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …
[PDF] academia.edu

[PDF][PDF] The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era

IZ Renault, V Scholl, R Hassan, P Capelleti… - Rev Bras Hematol …, 2011 - academia.edu
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid
leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular …